Decoy Therapeutics Inc. Retained Earnings
Decoy Therapeutics Inc. (DCOY) had Retained Earnings of -$99.04 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-12
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$99.04M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$96.67M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$94.44M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$85.46M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$99.04M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | -$96.67M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | -$94.44M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | -$85.46M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$84.59M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | -$83.63M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | -$81.92M 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$80.46M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$79.49M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | -$78.06M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | -$76.35M 10-K · filed 2025-03-21 | |
| 2023-09-30 | -$75.47M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$73.02M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | -$69.15M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$63.81M 10-K · filed 2024-03-22 | |
| 2022-09-30 | -$57.43M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$43.02M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | -$38.31M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | -$32.20M 10-K · filed 2023-03-27 | |
| 2021-09-30 | -$28.09M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | -$24.36M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | -$21.28M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | -$19.43M 10-K · filed 2022-03-25 | |
| 2020-09-30 | -$17.66M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | -$15.94M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | -$14.16M 10-Q/A · filed 2020-05-15 | |
| 2019-12-31 | -$12.08M 10-K · filed 2021-03-18 | |
| 2019-09-30 | -$10.19M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | -$136.58M 10-Q · filed 2019-07-17 | |
| 2019-03-31 | -$135.19M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | -$5.14M 10-K · filed 2020-03-23 | -$132.96M 10-K · filed 2019-03-06 |
| 2018-09-30 | -$130.95M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | -$128.31M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | -$119.26M 10-Q · filed 2018-05-02 | |
| 2017-12-31 | -$111.08M 10-K · filed 2019-03-06 | |
| 2017-09-30 | -$103.05M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | -$93.72M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | -$84.91M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | -$76.65M 10-K · filed 2018-03-07 | |
| 2016-09-30 | -$68.75M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | -$58.11M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | -$46.74M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | -$37.15M 10-K · filed 2017-03-08 | |
| 2015-09-30 | -$29.26M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | -$21.11M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | -$14.03M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | -$8.01M 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |